Shijiazhuang Yiling Pharmaceutical Co Ltd Financial Flexibility Index
Shijiazhuang Yiling Pharmaceutical Co Ltd financial flexibility index. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥530.90 Million (operating CF CN¥446.51 Million minus capex CN¥84.38 Million) represents 0% of total liabilities (CN¥3.52 Billion). See 002603 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Financial flexibility index of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. Historical Financial Flexibility Index trend for Shijiazhuang Yiling Pharmaceutical Co Ltd across 18 annual periods. Check Shijiazhuang Yiling Pharmaceutical Co Lt cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Shijiazhuang Yiling Pharmaceutical Co Ltd Financial Flexibility Index by Year (2008–2025)
Shijiazhuang Yiling Pharmaceutical Co Ltd financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Shijiazhuang Yiling Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Shijiazhuang Yiling Pharmaceutical Co Lt (002603) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.75x | CN¥2.02 Billion | CN¥1.78 Billion | CN¥2.69 Billion | ▲ +159.6% |
| 2024 | 0.29x | CN¥901.40 Million | CN¥611.01 Million | CN¥3.12 Billion | ▲ +243.7% |
| 2023 | 0.08x | CN¥466.29 Million | CN¥155.46 Million | CN¥5.54 Billion | ▼ -87.7% |
| 2022 | 0.68x | CN¥3.70 Billion | CN¥3.49 Billion | CN¥5.41 Billion | ▲ +118.1% |
| 2021 | 0.31x | CN¥1.20 Billion | CN¥528.69 Million | CN¥3.83 Billion | ▼ -70.3% |
| 2020 | 1.06x | CN¥2.73 Billion | CN¥1.59 Billion | CN¥2.58 Billion | ▲ +125.5% |
| 2019 | 0.47x | CN¥523.35 Million | CN¥68.93 Million | CN¥1.12 Billion | ▲ +79.3% |
| 2018 | 0.26x | CN¥259.59 Million | CN¥72.37 Million | CN¥993.56 Million | ▼ -31.3% |
| 2017 | 0.38x | CN¥295.00 Million | CN¥114.65 Million | CN¥775.58 Million | ▼ -65.3% |
| 2016 | 1.10x | CN¥1.01 Billion | CN¥641.45 Million | CN¥925.04 Million | ▲ +58.0% |
| 2015 | 0.69x | CN¥610.31 Million | CN¥131.88 Million | CN¥879.56 Million | ▼ -16.3% |
| 2014 | 0.83x | CN¥556.10 Million | CN¥105.90 Million | CN¥671.19 Million | ▼ -28.8% |
| 2013 | 1.16x | CN¥465.15 Million | CN¥55.32 Million | CN¥399.69 Million | ▲ +1.7% |
| 2012 | 1.14x | CN¥367.02 Million | CN¥70.13 Million | CN¥320.75 Million | ▲ +359.9% |
| 2011 | -0.44x | CN¥-230.59 Million | CN¥-408.49 Million | CN¥523.78 Million | ▼ -151.2% |
| 2010 | 0.86x | CN¥584.74 Million | CN¥299.72 Million | CN¥680.08 Million | ▲ +16.9% |
| 2009 | 0.74x | CN¥528.78 Million | CN¥318.21 Million | CN¥718.89 Million | ▼ -24.4% |
| 2008 | 0.97x | CN¥338.45 Million | CN¥210.18 Million | CN¥347.88 Million | — |